Published in Blood on April 01, 2002
The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood (2009) 3.56
The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol (2005) 2.42
High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood (2010) 2.37
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood (2006) 2.32
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc Natl Acad Sci U S A (2010) 2.10
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma. Leuk Lymphoma (2009) 1.71
Pathogenesis of follicular lymphoma. J Clin Invest (2012) 1.66
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma. Blood (2015) 1.53
Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc Natl Acad Sci U S A (2014) 1.28
Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures. Nat Rev Cancer (2009) 1.17
DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. Blood (2015) 1.15
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci U S A (2010) 1.14
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes. J Clin Invest (2004) 1.10
Self-antigen recognition by follicular lymphoma B-cell receptors. Blood (2012) 0.95
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Mod Pathol (2016) 0.90
Nature and importance of follicular lymphoma precursors. Haematologica (2014) 0.85
Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells. Vaccine (2008) 0.83
Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies. BMC Immunol (2012) 0.82
Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J Immunol (2013) 0.81
Biased immunoglobulin light chain use in the Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. Am J Hematol (2013) 0.80
Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR. Glycoconj J (2008) 0.79
Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. MAbs (2014) 0.79
Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease. Mediterr J Hematol Infect Dis (2009) 0.78
Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses. Immunology (2002) 0.78
Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody. Malar J (2015) 0.77
Glycosylation of V region genes in follicular lymphoma as a result of the somatic hypermutation mechanism. Blood (2002) 0.77
N-glycoprotein macroheterogeneity: biological implications and proteomic characterization. Glycoconj J (2015) 0.77
Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses. World J Clin Oncol (2011) 0.76
Hybridoma-Derived Idiotype Vaccine for Lymphoma: Approval Must Wait. Pharmaceuticals (Basel) (2010) 0.75
Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans. Mol Cell Proteomics (2016) 0.75
Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity. Haematologica (2016) 0.75
Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity? Nat Rev Rheumatol (2017) 0.75
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med (2013) 6.70
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med (2015) 5.69
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. N Engl J Med (2015) 5.44
Guidelines on the diagnosis and management of Waldenström macroglobulinaemia. Br J Haematol (2014) 2.80
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet (2004) 2.79
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging (2010) 2.48
DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer (2008) 2.23
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial. Blood (2008) 2.17
Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods (2008) 2.03
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood (2008) 2.00
Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid. Eur J Immunol (2010) 1.65
Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood (2008) 1.63
In vivo preclinical photoacoustic imaging of tumor vasculature development and therapy. J Biomed Opt (2012) 1.59
Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol (2007) 1.55
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood (2007) 1.55
DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance. Blood (2008) 1.51
Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood (2003) 1.49
Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol (2002) 1.45
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology (2005) 1.41
C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood (2004) 1.41
Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res (2006) 1.39
DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther (2009) 1.34
Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Health Psychol (2004) 1.33
Effective in-service training design and delivery: evidence from an integrative literature review. Hum Resour Health (2013) 1.23
Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood (2005) 1.23
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J Biol Chem (2006) 1.19
Left frontal cortical activation and spreading of alternatives: tests of the action-based model of dissonance. J Pers Soc Psychol (2008) 1.19
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol (2013) 1.18
Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. J Immunol (2005) 1.18
The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood (2009) 1.15
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci U S A (2010) 1.14
Primary mediastinal large B-cell lymphoma. Crit Rev Oncol Hematol (2008) 1.12
Social barriers to emotional expression and their relations to distress in male and female cancer patients. Br J Health Psychol (2003) 1.11
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood (2011) 1.11
Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol (2002) 1.11
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. Blood (2011) 1.09
Response to Nelissen et al., Helping mothers survive bleeding after birth: an evaluation of simulation-based training in a low-resource setting. Acta Obstet Gynecol Scand (2014) 1.08
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function. Blood (2013) 1.05
Harmonization of the intracellular cytokine staining assay. Cancer Immunol Immunother (2012) 1.05
Leadership in surgery for public sector hospitals in Jamaica: strategies for the operating room. Perm J (2013) 1.04
Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. J Alzheimers Dis (2007) 1.04
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study. Br J Haematol (2006) 1.03
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines. Cancer Immunol Immunother (2008) 1.03
Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. PLoS One (2009) 1.03
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia? Leuk Res (2006) 1.02
Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells. Blood (2004) 1.02
A single locus is responsible for salinity tolerance in a Chinese landrace barley (Hordeum vulgare L.). PLoS One (2012) 1.02
Immunotherapy of hematologic malignancy. Hematology Am Soc Hematol Educ Program (2003) 1.00
Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Hum Mutat (2011) 0.99
Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J Neurochem (2005) 0.99
DNA vaccines against cancer come of age. Curr Opin Immunol (2010) 0.99
Chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program (2002) 0.99
Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses. Int Immunol (2010) 0.99
Mechanism of action of rituximab. Anticancer Drugs (2002) 0.98
DNA vaccines to attack cancer. Proc Natl Acad Sci U S A (2004) 0.98
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood (2002) 0.98
Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection. Autoimmunity (2004) 0.97
Public T cell receptor beta-chains are not advantaged during positive selection. J Immunol (2008) 0.96
Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood (2002) 0.95
Fabrication and characterization of a multilayered optical tissue model with embedded scattering microspheres in polymeric materials. Biomed Opt Express (2012) 0.95
In vivo photoacoustic imaging of mouse embryos. J Biomed Opt (2012) 0.94
Novel antibodies targeting immune regulatory checkpoints for cancer therapy. Br J Clin Pharmacol (2013) 0.94
The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood (2002) 0.93
Have we been wrong about ionizing radiation and chronic lymphocytic leukemia? Leuk Res (2007) 0.93
DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol Rev (2004) 0.93
Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen. J Immunol (2002) 0.93
Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br J Haematol (2003) 0.92
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment. Health Qual Life Outcomes (2012) 0.92
Breast cancer is a promising target for vaccination using cancer-testis antigens known to elicit immune responses. Breast Cancer Res (2007) 0.92
Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. Blood (2010) 0.91
Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. Blood (2004) 0.91
A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur J Immunol (2002) 0.90
Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells. J Immunol (2006) 0.90
Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Mol Immunol (2007) 0.90
Sharing best practices through online communities of practice: a case study. Hum Resour Health (2010) 0.90
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. Blood (2013) 0.90
Multicenter retrospective analysis of the solid-screw ITI implant for posterior single-tooth replacements. Int J Oral Maxillofac Implants (2002) 0.89
Fourier transform infrared imaging and infrared fiber optic probe spectroscopy identify collagen type in connective tissues. PLoS One (2013) 0.89
Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class I complexes. Eur J Immunol (2008) 0.89
Measuring low back injury risk factors in challenging work environments: an evaluation of cost and feasibility. Am J Ind Med (2007) 0.89
Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma. Blood (2003) 0.88